Gujarat Inject [GUJINJEC] vs Dishman Carbogen [DCAL] Detailed Stock Comparison

Gujarat Inject (Kerala) Ltd.

BSE
Loading...

Dishman Carbogen Amcis Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Gujarat Inject (Kerala) Ltd. wins in 4 metrics, Dishman Carbogen Amcis Ltd. wins in 14 metrics, with 1 ties. Dishman Carbogen Amcis Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Gujarat Inject (Kerala) Ltd. Dishman Carbogen Amcis Ltd. Better
P/E Ratio (TTM) 158.27 22.30 Dishman Carbogen Amcis Ltd.
Price-to-Book Ratio 12.63 0.42 Dishman Carbogen Amcis Ltd.
Debt-to-Equity Ratio 0.00 40.20 Tie
PEG Ratio -2.01 -0.16 Dishman Carbogen Amcis Ltd.
EV/EBITDA 93.74 9.62 Dishman Carbogen Amcis Ltd.
Profit Margin (TTM) 2.51% 4.25% Dishman Carbogen Amcis Ltd.
Operating Margin (TTM) 2.88% 3.99% Dishman Carbogen Amcis Ltd.
EBITDA Margin (TTM) 2.88% 3.99% Dishman Carbogen Amcis Ltd.
Return on Equity 10.16% 0.06% Gujarat Inject (Kerala) Ltd.
Return on Assets (TTM) 8.51% 0.03% Gujarat Inject (Kerala) Ltd.
Free Cash Flow (TTM) $-15.46M $1.58B Dishman Carbogen Amcis Ltd.
1-Year Return 425.15% -33.95% Gujarat Inject (Kerala) Ltd.
Price-to-Sales Ratio (TTM) 13.82 0.95 Dishman Carbogen Amcis Ltd.
Enterprise Value $1.18B $46.55B Dishman Carbogen Amcis Ltd.
EV/Revenue Ratio 11.69 1.66 Dishman Carbogen Amcis Ltd.
Gross Profit Margin (TTM) 0.14% 80.34% Dishman Carbogen Amcis Ltd.
Revenue per Share (TTM) $11 $179 Dishman Carbogen Amcis Ltd.
Earnings per Share (Diluted) $0.60 $7.58 Dishman Carbogen Amcis Ltd.
Beta (Stock Volatility) -0.90 0.40 Gujarat Inject (Kerala) Ltd.

Gujarat Inject (Kerala) Ltd. vs Dishman Carbogen Amcis Ltd. Stock Performance Analysis

Loading Price Chart...

GUJINJEC
DCAL

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Gujarat Inject (Kerala) Ltd.-1.68%-2.42%13.59%63.41%279.75%225.27%
Dishman Carbogen Amcis Ltd.-2.38%-2.24%-7.21%9.02%-19.76%-29.73%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Gujarat Inject (Kerala) Ltd.425.15%1,090.00%3,947.62%3,947.62%3,947.62%3,947.62%
Dishman Carbogen Amcis Ltd.-33.95%46.77%-6.77%33.46%290.77%118.12%

Performance & Financial Health Analysis: Gujarat Inject (Kerala) Ltd. vs Dishman Carbogen Amcis Ltd.

MetricGUJINJECDCAL
Market Information
Market Cap i₹1.38B₹26.50B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i22,292337,264
90 Day Avg. Volume i41,507517,904
Last Close₹117.00₹180.24
52 Week Range₹19.01 - ₹125.50₹128.50 - ₹321.95
% from 52W High-6.77%-44.02%
All-Time High₹125.50 (Jun 09, 2026)₹396.40 (Jan 22, 2018)
% from All-Time High-6.77%-54.53%
Growth Metrics
Quarterly Revenue Growth-0.44%0.06%
Quarterly Earnings Growth-0.82%-0.09%
Financial Health
Profit Margin (TTM) i0.03%0.04%
Operating Margin (TTM) i0.03%0.04%
Return on Equity (TTM) i0.10%0.00%
Debt to Equity (MRQ) i0.0040.20
Cash & Liquidity
Book Value per Share (MRQ)₹7.52₹405.67
Cash per Share (MRQ)₹0.18₹40.41
Operating Cash Flow (TTM) i₹-31,076,498₹-199,700,000
Levered Free Cash Flow (TTM) i₹10.17M₹32.40M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A₹0.00

Valuation & Enterprise Metrics Analysis: Gujarat Inject (Kerala) Ltd. vs Dishman Carbogen Amcis Ltd.

MetricGUJINJEC (Apr 24, 2026)DCAL (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i158.2722.30
Forward P/E iN/A13.52
PEG Ratio i-2.01-0.16
Price to Sales (TTM) i13.820.95
Price to Book (MRQ) i12.630.42
Market Capitalization
Market Capitalization i₹1.38B₹26.50B
Enterprise Value i₹1.18B₹46.55B
Enterprise Value Metrics
Enterprise to Revenue i11.691.66
Enterprise to EBITDA i93.749.62
Risk & Other Metrics
Beta i-0.900.40
Book Value per Share (MRQ) i₹7.52₹405.67

Financial Statements Comparison: Gujarat Inject (Kerala) Ltd. vs Dishman Carbogen Amcis Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricGUJINJEC (2025)DCAL (2025)
Revenue/Sales i190.46M26.42B
Cost of Goods Sold i177.77M5.26B
COGS % of Revenue i93.3%19.9%
Gross Profit i12.68M21.16B
Gross Margin i6.7%80.1%
Research & Development iN/AN/A
Operating Income (EBIT) i10.75M1.46B
Operating Margin i5.6%5.5%
EBITDA i12.56M4.83B
EBITDA Margin i6.6%18.3%
Pre-Tax Income i12.54M193.10M
Pre-Tax Income % of Revenue i6.6%0.7%
Income Tax i2.37M160.70M
Income Tax % of Revenue i1.2%0.6%
Net Income (Profit) i10.17M32.40M
Profit Margin i5.3%0.1%

Balance Sheet & Liquidity Metrics

MetricGUJINJEC (2025)DCAL (2025)
Cash & Equivalents i262,7852.86B
Total Current Assets i99.75M22.00B
Total Current Assets % of Revenue i52.4%83.3%
Total Current Liabilities i19.38M19.25B
Total Current Liabilities % of Revenue i10.2%72.9%
Long-Term Debt i013.90B
Long-Term Debt % of Revenue i0.0%52.6%
Total Shareholders Equity i100.12M58.32B
Retained Earnings iN/A2.13B
Retained Earnings % of Revenue i0.0%8.1%
Property, Plant & Equipment iN/A10.27B

Cash Flow Statement Comparison

MetricGUJINJEC (2025)DCAL (2025)
Operating Cash Flow i-31.08M-199.70M
Operating Cash Flow % of Revenue i-16.3%-0.8%
Capital Expenditures i0-2.15B
Free Cash Flow i-15.46M1.58B
FCF Margin i-8.1%6.0%
Debt Repayment i-19.76M-1.10B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricGUJINJECDCAL
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i14.65M156.78M
Float Shares i1.00M54.95M
% Held by Insiders i63.90%69.30%
% Held by Institutions i0.00%2.41%
% Held by Public i36.10%28.29%

Dividend Analysis & Yield Comparison: Gujarat Inject (Kerala) Ltd. vs Dishman Carbogen Amcis Ltd.

MetricGUJINJECDCAL
Last 12-Month Dividend iN/A₹0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A₹0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/A₹0.00
Ex-Dividend DateN/AN/A